×

Teva to acquire Allergan for $40B

11:11 AM ET Mon, 27 July 2015

A major deal in the pharma space, Teva says it will buy Allergan's generics business in a deal worth a little over 40 billion dollars. CNBC's Meg Tirrell reports the details.